Evidence of innate lymphoid cell redundancy in humans

Nature Immunology

Volumn 17, Issue 11, 2016, Pages 1291-1299

  Vély, Frédéric ^a,b   Barlogis, Vincent ^c   Vallentin, Blandine ^c   Neven, Bénédicte ^d,e,f   Piperoglou, Christelle ^a,b   Ebbo, Mikael ^a,c   Perchet, Thibaut ^e,g   Petit, Maxime ^e,g   Yessaad, Nadia ^h   Touzot, Fabien ^d,e   Bruneau, Julie ^d,e   Mahlaoui, Nizar ^d,e,f   Zucchini, Nicolas ⁱ   Farnarier, Catherine ^b   Michel, Gérard ^d   Moshous, Despina ^d,e,f   Blanche, Stéphane ^d,e,f   Dujardin, Arnaud ^j   Spits, Hergen ^k   Distler, Jörg H W ^l   Ramming, Andreas ^l   Picard, Capucine ^d,e,f   Golub, Rachel ^e,g   Fischer, Alain ^d,e,f,m   Vivier, Eric ^a   more..

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c TIMONE HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f INSERM   (France)

^g INSTITUT PASTEUR   (France)

^h AIX MARSEILLE UNIVERSITY   (France)

ⁱ BD Biosciences   (France)

^j INNATE PHARMA   (France)

^k UNIVERSITY OF AMSTERDAM   (Netherlands)

^l UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^m Centre de Recherche Interdisciplinaire en Biologie   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 22; INTERLEUKIN 5; INTERLEUKIN 7; JANUS KINASE; BIOLOGICAL MARKER; JANUS KINASE 3;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FOLLOW UP; GENE MUTATION; GROUPS BY AGE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; JAK3 DEFICIENCY; LYMPHOID CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SEVERE COMBINED IMMUNODEFICIENCY; T LYMPHOCYTE; UMBILICAL CORD BLOOD; ADOLESCENT; ANIMAL; BLOOD; CYTOLOGY; DEFICIENCY; DISEASE MODEL; GRAFT SURVIVAL; IMMUNE SYSTEM; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE MUCOSA; KNOCKOUT MOUSE; LYMPHOCYTE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOPENIA; METABOLISM; PATHOLOGY; PHENOTYPE; SKIN;

ADOLESCENT; ADULT; ANIMALS; BIOMARKERS; CHILD; DISEASE MODELS, ANIMAL; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; INTESTINAL MUCOSA; JANUS KINASE 3; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; LYMPHOCYTES; LYMPHOPENIA; MICE; MICE, KNOCKOUT; PHENOTYPE; SEVERE COMBINED IMMUNODEFICIENCY; SKIN;

EID: 84987619415     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3553     Document Type: Article

References (50)

1. Klose, C. S. & Artis, D. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat. Immunol. 17, 765-774 (2016).
2. Spits, H. et al. Innate lymphoid cells - A proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145-149 (2013).
3. Eberl, G., Colonna, M., Di Santo, J. P. & McKenzie, A. N. Innate lymphoid cells. Innate lymphoid cells: A new paradigm in immunology. Science 348, aaa6566 (2015).
4. Juelke, K. & Romagnani, C. Differentiation of human innate lymphoid cells (ILCs). Curr. Opin. Immunol. 38, 75-85 (2016).
5. Renoux, V. M. et al. Identification of a human natural killer cell lineage-restricted progenitor in fetal and adult tissues. Immunity 43, 394-407 (2015).
6. Montaldo, E., Juelke, K. & Romagnani, C. Group 3 innate lymphoid cells (ILC3s): origin, differentiation, and plasticity in humans and mice. Eur. J. Immunol. 45, 2171-2182 (2015).
7. Scoville, S. D. et al. A progenitor cell expressing transcription factor RORt generates all human innate lymphoid cell subsets. Immunity 44, 1140-1150 (2016).
8. Buckley, R. H. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu. Rev. Immunol. 22, 625-655 (2004).
9. Fischer, A., Hacein-Bey-Abina, S. & Cavazzana-Calvo, M. Gene therapy for primary adaptive immune deficiencies. J. Allergy Clin. Immunol. 127, 1356-1359 (2011).
10. Gennery, A. R. et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better J. Allergy Clin. Immunol. 126, 602-610 (2010).
11. Buckley, R. H. Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes. Immunol. Res. 49, 25-43 (2011).
12. Fischer, A. Primary immunodeficiency diseases: An experimental model for molecular medicine. Lancet 357, 1863-1869 (2001).
13. Rankin, L. C. et al. Complementarity and redundancy of IL-22-producing innate lymphoid cells. Nat. Immunol. 17, 179-186 (2016).
14. Song, C. et al. Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation. J. Exp. Med. 212, 1869-1882 (2015).
15. Gasteiger, G., Fan, X., Dikiy, S., Lee, S. Y. & Rudensky, A. Y. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350, 981-985 (2015).
16. Munneke, J. M. et al. Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease. Blood 124, 812-821 (2014).
17. Hazenberg, M. D. & Spits, H. Human innate lymphoid cells. Blood 124, 700-709 (2014).
18. Vallentin, B. et al. Innate lymphoid cells in cancer. Cancer Immunol. Res. 3, 1109-1114 (2015).
19. Kløverpris, H. N. et al. Innate lymphoid cells are depleted irreversibly during acute HIV-1 infection in the absence of viral suppression. Immunity 44, 391-405 (2016).
20. Huntington, N. D., Carpentier, S., Vivier, E. & Belz, G. T. Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells. Curr. Opin. Immunol. 38, 86-93 (2016).
21. Buckley, R. H. et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J. Pediatr. 130, 378-387 (1997).
22. Stephan, J. L. et al. Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patients. J. Pediatr. 123, 564-572 (1993).
23. McKenzie, A. N., Spits, H. & Eberl, G. Innate lymphoid cells in inflammation and immunity. Immunity 41, 366-374 (2014).
24. Diefenbach, A., Colonna, M. & Koyasu, S. Development, differentiation, and diversity of innate lymphoid cells. Immunity 41, 354-365 (2014).
25. Artis, D. & Spits, H. The biology of innate lymphoid cells. Nature 517, 293-301 (2015).
26. Neven, B. et al. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood 113, 4114-4124 (2009).
27. Fischer, A. et al. Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol. Rev. 203, 98-109 (2005).
28. Robinette, M. L. et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat. Immunol. 16, 306-317 (2015).
29. Björklund, A. K. et al. The heterogeneity of human CD127+ innate lymphoid cells revealed by single-cell RNA sequencing. Nat. Immunol. 17, 451-460 (2016).
30. Roan, F. et al. CD4+ group 1 innate lymphoid cells (ILC) form a functionally distinct ilc subset that is increased in systemic sclerosis. J. Immunol. 196, 2051-2062 (2016).
31. Fuchs, A. et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12-and IL-15-responsive IFN-producing cells. Immunity 38, 769-781 (2013).
32. Wohlfahrt, T. et al. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis. Ann. Rheum. Dis. 75, 623-626 (2016).
33. Koyasu, S. Inflammatory ILC2 cells: disguising themselves as progenitors Nat. Immunol. 16, 133-134 (2015).
34. Czechowicz, A., Kraft, D., Weissman, I. L. & Bhattacharya, D. Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science 318, 1296-1299 (2007).
35. Railey, M. D., Lokhnygina, Y. & Buckley, R. H. Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis. J. Pediatr. 155, 834-840. e1 (2009).
36. Laffort, C. et al. Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency. Lancet 363, 2051-2054 (2004).
37. Goldschmidt, M. H. et al. Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs. J. Virol. 80, 6621-6628 (2006).
38. Nishio, H., Matsui, K., Tsuji, H., Tamura, A. & Suzuki, K. Immunolocalisation of the janus kinases (JAK) signal transducers and activators of transcription (STAT) pathway in human epidermis. J. Anat. 198, 581-589 (2001).
39. Recher, M. et al. IL-21 is the primary common chain-binding cytokine required for human B-cell differentiation in vivo. Blood 118, 6824-6835 (2011).
40. Huntington, N. D. et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 206, 25-34 (2009).
41. Satoh-Takayama, N. et al. IL-7 and IL-15 independently program the differentiation of intestinal CD3NKp46+ cell subsets from Id2-dependent precursors. J. Exp. Med. 207, 273-280 (2010).
42. Kang, J. & Coles, M. IL-7: The global builder of the innate lymphoid network and beyond, one niche at a time. Semin. Immunol. 24, 190-197 (2012).
43. Cavazzana-Calvo, M. et al. Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype. Blood 109, 4575-4581 (2007).
44. Ruggeri, L., Aversa, F., Martelli, M. F. & Velardi, A. Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. Immunol. Rev. 214, 202-218 (2006).
45. Fan, X. & Rudensky, A. Y. Hallmarks of Tissue-Resident Lymphocytes. Cell 164, 1198-1211 (2016).
46. Perdiguero, E. G. & Geissmann, F. The development and maintenance of resident macrophages. Nat. Immunol. 17, 2-8 (2016).
47. Bando, J. K. & Colonna, M. Innate lymphoid cell function in the context of adaptive immunity. Nat. Immunol. 17, 783-789 (2016).
48. Parry, D. A. et al. A homozygous STIM1 mutation impairs store-operated calcium entry and natural killer cell effector function without clinical immunodeficiency. J. Allergy Clin. Immunol. 137, 955-957 (2016).
49. Boulenouar, S. et al. The residual innate lymphoid cells in NFIL3-Deficient mice support suboptimal maternal adaptations to pregnancy. Front. Immunol. 7, 43 (2016).
50. Tomasello, E. et al. Mapping of NKp46+ cells in healthy human lymphoid and non-lymphoid tissues. Front. Immunol. 3, 344 (2012).